Clinical experiences with beta-adrenergic blocking agents.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004983:Ethanolamines / Q000627:therapeutic use; D006331:Heart Diseases / Q000188:drug therapy; D006439:Hemodynamics; D006801:Humans; D005082:Physical Exertion; D011433:Propranolol / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D013565:Sympatholytics / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D004983:Ethanolamines; D013565:Sympatholytics; D011433:Propranolol